Leadership Overview
Avara Pharmaceutical Services has 4 executives leading key functions including operations, finance, human resources, and executive leadership.
Driven by a commitment to manufacturing excellence, Avara Pharmaceutical Services provides comprehensive pharmaceutical services, focusing on aseptic liquid filling, sterile injectables, and oral solid dose manufacturing to meet critical market demands.
Driven by a commitment to manufacturing excellence, Avara Pharmaceutical Services provides comprehensive pharmaceutical services, focusing on aseptic liquid filling, sterile injectables, and oral solid dose manufacturing to meet critical market demands.
Leadership Roles at Avara Pharmaceutical Services
Kunal Bahl - Group Chief Financial Officer, Finance Lead For Automotive & Pharma
Kunal Bahl, the Group Chief Financial Officer, Finance Lead For Automotive & Pharma at Avara Pharmaceutical Services, manages all financial strategies and fiscal operations. Bahl oversees the financial health of the pharmaceutical division, ensuring robust financial planning, accurate reporting, and effective capital allocation. This critical position involves guiding investment decisions and managing financial risks inherent in the pharmaceutical manufacturing sector. By optimizing financial performance, Kunal Bahl directly contributes to the company's growth and stability. The Group Chief Financial Officer, Finance Lead For Automotive & Pharma's responsibilities include developing long-term financial forecasts and managing relationships with financial institutions. Bahl's expertise ensures that Avara Pharmaceutical Services maintains a strong financial foundation to support its manufacturing and packaging solutions.
Larry Lee - Chief Operating Officer
Larry Lee, the Chief Operating Officer at Avara Pharmaceutical Services, directs all manufacturing operations. Overseeing aseptic liquid filling, sterile pharmaceutical production, oral solid dose manufacturing, and packaging solutions, Lee ensures the efficient execution of the company's core services. This leadership role involves optimizing production workflows and maintaining the highest standards of quality control across all operational units. By driving process improvements, Larry Lee directly impacts the company's capacity to deliver sterile injectables and other critical pharmaceutical products. Lee's focus on operational excellence supports Avara Pharmaceutical Services' mission to be a leading manufacturing organization. The Chief Operating Officer's oversight extends to managing resources and personnel to achieve production targets and uphold regulatory compliance. Lee ensures seamless integration of new technologies and methodologies to enhance manufacturing capabilities.

Robert Rothmann - President
Robert Rothmann, the President at Avara Pharmaceutical Services, provides overarching strategic direction and executive leadership. Rothmann guides the company's vision, ensuring alignment across all departments, including manufacturing, finance, and human resources. This executive role involves setting the strategic priorities for Avara Pharmaceutical Services, driving market expansion, and fostering key stakeholder relationships. By championing innovation and operational excellence, Robert Rothmann directly shapes the company's trajectory in the pharmaceutical manufacturing landscape. The President's responsibilities encompass overseeing the company's overall performance and ensuring its continued success in offering aseptic liquid filling, sterile injectables, and oral solid dose solutions. Rothmann's leadership ensures Avara Pharmaceutical Services remains a trusted partner for packaging solutions and sterile pharmaceutical production.
Richard Mark - Chief Human Resources Officer
Richard Mark, the Chief Human Resources Officer at Avara Pharmaceutical Services, leads all human capital initiatives and organizational development. Mark is responsible for cultivating a high-performance culture, managing talent acquisition, and overseeing employee relations across the manufacturing organization. This role is pivotal in ensuring that Avara Pharmaceutical Services attracts and retains the skilled workforce necessary for complex pharmaceutical production. By fostering a supportive and productive work environment, Richard Mark directly enhances the company's operational capabilities. The Chief Human Resources Officer's strategic focus includes developing comprehensive compensation and benefits programs and implementing effective training and development strategies. Mark ensures that human resources functions align with the company's mission to provide sterile injectables and other vital pharmaceutical services.
Explore Leadership Teams in Manufacturing
Kyowa Kirin is a global specialty pharmaceutical company focused on antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. They are headquartered in Tokyo, Japan.
Company Leadership SI
CS
TS
JC
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership GT
RV
LP
MT
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership
HK
Chemipharm is the only company selling directly to 100% of the reachable pharmacies and hospitals in Egypt. Chemipharm's distribution network includes: 12 branches allover Egypt. 100 fixed routes every day. Total 150 visiting all the pharmacies all over the country. Latest News : PROFILE Company Profile: Chemipharm was founded in 1972 by Dr. Gamal Kamel as the first private sector importer of pharmaceutical products in Egypt. Over the last 35 years, Chemipharm has developed and maintained an invaluable reputation as Egypt's most respectable and high standards pharmaceutical distributor. In 2003, based on the company's continuous growth, Chemipharm has established its own manufacturing facility in the 6th of October Industrial Zone. Plant was designed by Pharma Consult. The modern GMP plant produces pharmaceutical products of all major forms (tablets, capsules, syrups and ointments). Presently Chemipharm is constructing a new sterile area to produce ampoules, eye drops and antibiotics. The company's strategy is based on continuous improvement and growth.
Company Leadership KK
NM
DO